About this sample
This is an illustrative sample using early-phase clinical research as the example category, demonstrating the report format for research partners rather than manufacturers.
Why this category is instructive
Buyers evaluating early-phase CROs typically ask AI about specific therapeutic area experience, first-in-human trial volume, and regulatory submission track record in particular jurisdictions. This category shows how much AI responses depend on an organisation stating its therapeutic and regulatory specialisation explicitly, rather than describing itself as a general clinical research provider.
Illustrative finding pattern
In our demonstration sampling, AI tools answering early-phase clinical prompts tended to favour organisations that had clearly published their therapeutic area focus and first-in-human experience, while generalist descriptions were often passed over in favour of better-documented, more narrowly specialised names.
What the full report includes
A completed report for an early-phase CRO client documents exactly which therapeutic and regulatory prompts surface the organisation today, which do not, and the specific content changes required to close the gap — followed by execution.